New studies show that patients with moderate to severe Crohn’s disease can maintain remission through three years of therapy with adalimumab (HUMIRA®). It appears that not only has adalimumab demonstrated its efficacy at the beginning of the treatment but it has also shown to maintain its effectiveness over the long-term - pretty important when considering how to manage a chronic condition like Crohn’s disease.
A secondary analysis of the same study demonstrated that patients being treated with adalimumab for Crohn's disease may also be able to achieve long-term steroid-free remission.
A disease of long duration generally involving slow changes.
Full medical glossary
Myocardial infarction. Death of a segment of heart muscle, which follows interruption of its blood supply.
Full medical glossary
rheumatoid arthritis
Full medical glossary
The lessening or disappearance of the symptoms or signs of a disease.
Full medical glossary